PharmacoNER/NN
Tagger/NN
:/:
a/DT
deep/JJ
learning-based/VBD
tool/NN
for/IN
automatically/RB
finding/NN
chemicals/NNS
and/CC
drugs/NNS
in/IN
Spanish/JJ
medical/JJ
texts/NNS
./.
====================
Automatically/RB
detecting/VBG
mentions/NNS
of/IN
pharmaceutical/JJ
drugs/NNS
and/CC
chemical/JJ
substances/NNS
is/VBZ
key/JJ
for/IN
the/DT
subsequent/JJ
extraction/NN
of/IN
relations/NNS
of/IN
chemicals/NNS
with/IN
other/JJ
biomedical/JJ
entities/VBZ
such/JJ
as/IN
genes/NNS
,/,
proteins/NNS
,/,
diseases/NNS
,/,
adverse/JJ
reactions/NNS
or/CC
symptoms/NNS
./.
====================
The/DT
identification/NN
of/IN
drug/NN
mentions/NNS
is/VBZ
also/RB
a/DT
prior/JJ
step/NN
for/IN
complex/NN
event/NN
types/NNS
such/JJ
as/IN
drug/NN
dosage/NN
recognition/NN
,/,
duration/NN
of/IN
medical/JJ
treatments/NNS
or/CC
drug/NN
repurposing/VBG
./.
====================
Formally/RB
,/,
this/DT
task/NN
is/VBZ
known/VBN
as/IN
named/VBN
entity/NN
recognition/NN
(/(
NER/NN
)/)
,/,
meaning/VBG
automatically/RB
identifying/VBG
mentions/NNS
of/IN
predefined/JJ
entities/VBZ
of/IN
interest/NN
in/IN
running/VBG
text/NN
./.
====================
In/IN
the/DT
domain/NN
of/IN
medical/JJ
texts/NNS
,/,
for/IN
chemical/JJ
entity/NN
recognition/NN
(/(
CER/NN
)/)
,/,
techniques/NNS
based/VBN
on/IN
hand-crafted/JJ
rules/NNS
and/CC
graph-based/JJ
models/NNS
can/MD
provide/VB
adequate/NN
performance/NN
./.
====================
In/IN
the/DT
recent/JJ
years/NNS
,/,
the/DT
field/NN
of/IN
natural/JJ
language/NN
processing/NN
has/VBZ
mainly/RB
pivoted/JJ
to/TO
deep/VB
learning/VBG
and/CC
state-of-the-art/NN
results/NNS
for/IN
most/JJS
tasks/VBZ
involving/VBG
natural/JJ
language/NN
are/VBP
usually/RB
obtained/VBN
with/IN
artificial/JJ
neural/JJ
networks/NNS
./.
====================
Competitive/JJ
resources/VBZ
for/IN
drug/NN
name/NN
recognition/NN
in/IN
English/NN
medical/JJ
texts/NNS
are/VBP
already/RB
available/JJ
and/CC
heavily/RB
used/VBN
,/,
while/IN
for/IN
other/JJ
languages/NNS
such/JJ
as/IN
Spanish/JJ
these/DT
tools/NNS
,/,
although/IN
clearly/RB
needed/VBN
were/VBD
missing/VBG
./.
====================
In/IN
this/DT
work/NN
,/,
we/PRP
adapt/VBP
an/DT
existing/VBG
neural/JJ
NER/NN
system/NN
,/,
NeuroNER/NN
,/,
to/TO
the/DT
particular/JJ
domain/NN
of/IN
Spanish/JJ
clinical/JJ
case/NN
texts/NNS
,/,
and/CC
extend/VBP
the/DT
neural/JJ
network/NN
to/TO
be/VB
able/JJ
to/TO
take/VB
into/IN
account/VBP
additional/JJ
features/NNS
apart/RB
from/IN
the/DT
plain/NN
text/RB
./.
====================
NeuroNER/NN
can/MD
be/VB
considered/VBN
a/DT
competitive/JJ
baseline/NN
system/NN
for/IN
Spanish/JJ
drug/NN
and/CC
CER/NN
promoted/VBD
by/IN
the/DT
Spanish/JJ
national/JJ
plan/NN
for/IN
the/DT
advancement/JJ
of/IN
language/JJ
technologies/NNS
(/(
Plan/NN
TL/NN
)/)
./.
====================
Availability/NN
:/:
PharmacoNER/NN
Tagger/NN
can/MD
be/VB
accessed/VBN
at/IN
https/NNS
:/:
//github.com/PlanTL-SANIDAD/PharmacoNER/NN
./.
====================
Chemical/JJ
compounds/NNS
and/CC
drugs/NNS
represent/VBP
a/DT
key/JJ
biomedical/JJ
entity/NN
of/IN
common/JJ
interest/NN
for/IN
a/DT
range/NN
of/IN
scientific/JJ
disciplines/NNS
,/,
including/VBG
medicine/JJ
and/CC
clinical/JJ
research/NN
,/,
pharmacology/NN
as/IN
well/RB
as/IN
basic/JJ
biomedical/JJ
research/NN
./.
====================
Due/IN
to/TO
the/DT
growing/VBG
amount/NN
of/IN
clinical/JJ
texts/NNS
,/,
medical/JJ
and/CC
biomedical/JJ
literature/NN
and/CC
medicinal/JJ
chemistry/NN
patents/NNS
,/,
a/DT
systematic/JJ
approach/NN
to/TO
recognize/VB
such/JJ
entities/VBZ
in/IN
order/NN
to/TO
semantically/RB
enrich/JJ
these/DT
documents/NNS
and/CC
enable/JJ
further/RBR
relation/NN
extraction/NN
task/NN
is/VBZ
needed/VBN
./.
====================
Text/RB
mining/VBG
and/CC
information/NN
extraction/NN
efforts/NNS
are/VBP
gradually/RB
being/VBG
adopted/VBN
to/TO
empower/RBR
the/DT
transformation/NN
of/IN
unstructured/JJ
running/VBG
texts/NNS
to/TO
more/RBR
structured/JJ
data/NNS
representations/VBZ
that/IN
can/MD
be/VB
directly/RB
consumed/VBN
by/IN
content/JJ
analytics/NNS
and/CC
information/NN
retrieval/JJ
infrastructures/VBZ
[/(
1/CD
]/)
.Semantically/RB
labeling/VBG
drug/NN
mentions/NNS
in/IN
medical/JJ
documents/VBZ
is/VBZ
a/DT
necessary/JJ
step/NN
to/TO
allow/VB
a/DT
range/NN
of/IN
downstream/JJ
text/RB
mining/VBG
applications/NNS
,/,
like/IN
drug-resistance/RB
,/,
drug/NN
dosage/JJ
recognition/NN
,/,
duration/IN
of/IN
medical/JJ
treatments/NNS
,/,
drug/NN
repurposing/VBG
,/,
detection/NN
of/IN
medication-related/JJ
allergies/VBZ
,/,
drug-drug/NN
interactions/NNS
or/CC
disease-drug/NN
relations/NNS
./.
====================
Drug/NN
names/NNS
show/VBP
some/DT
inherent/JJ
characteristics/NNS
such/JJ
as/IN
the/DT
constraints/NNS
imposed/VBN
by/IN
the/DT
International/JJ
Nonproprietary/JJ
Names/NNS
(/(
INN/NN
)/)
system/NN
by/IN
exploiting/VBG
certain/JJ
suffixes/NNS
and/CC
prefixes/NNS
to/TO
group/NN
them/PRP
according/VBG
to/TO
certain/JJ
attributes/NNS
./.
====================
For/IN
instance/NN
,/,
the/DT
suffix/JJ
‘/CD
-caine/JJ
’/CD
is/VBZ
usually/RB
used/VBN
for/IN
local/JJ
anesthetics/NNS
./.
====================
These/DT
properties/NNS
are/VBP
not/RB
only/RB
useful/JJ
for/IN
healthcare/JJ
professionals/NNS
and/CC
pharmacologists/NNS
to/TO
memorize/VB
drug/NN
names/NNS
,/,
their/PRP$
attributes/NNS
and/CC
fining/VBG
them/PRP
in/IN
the/DT
clinical/JJ
literature/NN
,/,
they/PRP
are/VBP
also/RB
constituting/VBG
valuable/JJ
attributes/VBZ
for/IN
automatically/RB
labeling/VBG
them/PRP
through/IN
language/JJ
technology/NN
tools.Named/VBD
entity/NN
recognition/NN
(/(
NER/NN
)/)
[/(
2/CD
]/)
is/VBZ
the/DT
task/NN
of/IN
automatically/RB
extracting/VBG
and/CC
identifying/VBG
mentions/NNS
of/IN
entities/VBZ
of/IN
interest/JJ
in/IN
running/VBG
text/RB
,/,
typically/RB
through/IN
their/PRP$
mention/JJ
offsets/VBZ
or/CC
by/IN
classifying/VBG
individual/JJ
tokens/NNS
whether/IN
they/PRP
belong/IN
to/TO
entity/NN
mentions/NNS
of/IN
not/RB
./.
====================
Among/IN
many/JJ
other/JJ
uses/VBZ
,/,
such/JJ
as/IN
entity-aware/JJ
machine/NN
translation/NN
,/,
NER/NN
can/MD
also/RB
be/VB
used/VBN
for/IN
the/DT
automated/JJ
information/NN
extraction/NN
and/CC
anonymization/NN
[/(
3/CD
]/)
of/IN
medical/JJ
texts/NNS
./.
====================
Early/JJ
techniques/NNS
involved/VBN
the/DT
use/NN
of/IN
hand-crafted/JJ
rules/NNS
./.
====================
The/DT
most/JJS
successful/JJ
approach/NN
consisted/VBD
in/IN
using/VBG
Conditional/JJ
Random/JJ
Fields/NNS
(/(
CRFs/NNS
)/)
,/,
a/DT
graph-based/JJ
model/NN
for/IN
modeling/VBG
sequences/NNS
that/WDT
still/RB
relied/VBD
on/IN
features/NNS
defined/VBN
by/IN
humans/NNS
./.
====================
In/IN
the/DT
last/JJ
years/NNS
,/,
Natural/JJ
Language/JJ
Processing/JJ
(/(
NLP/NN
)/)
techniques/NNS
have/VBP
been/VBN
improved/VBN
with/IN
the/DT
use/NN
of/IN
word/NN
embeddings/NNS
,/,
that/DT
is/VBZ
to/TO
say/VB
,/,
projections/NNS
of/IN
words/NNS
to/TO
vector/NN
spaces/VBZ
such/JJ
that/IN
among/IN
other/JJ
findings/NNS
,/,
the/DT
distance/NN
can/MD
be/VB
used/VBN
as/IN
a/DT
semantic/JJ
similarity/NN
measure/VB
[/(
4/CD
]/)
./.
====================
Deep/IN
learning/VBG
(/(
e.g./FW
,/,
artificial/JJ
neural/JJ
networks/NNS
[/(
ANNs/NNS
]/)
with/IN
a/DT
high/JJ
number/NN
of/IN
hidden/JJ
layers/NNS
)/)
has/VBZ
proved/VBN
to/TO
be/VB
extremely/RB
useful/JJ
in/IN
solving/JJ
NER/NN
problems/NNS
./.
====================
In/IN
this/DT
article/NN
,/,
we/PRP
introduce/VBP
PharmacoNER/NN
tagger/NN
,/,
NER/NN
software/JJ
based/VBN
on/IN
NeuroNER/NN
[/(
5/CD
]/)
adapted/VBN
to/TO
the/DT
domain/NN
of/IN
Spanish/JJ
medical/JJ
texts/NNS
and/CC
improved/VBD
with/IN
non-domain-specific/JJ
features/NNS
./.
====================
The/DT
problem/NN
====================
Medical/JJ
documents/VBZ
mentioning/VBG
drugs/NNS
and/CC
chemical/JJ
compounds/NNS
offer/VBP
a/DT
relevant/JJ
source/NN
of/IN
information/NN
regarding/VBG
the/DT
patients/NNS
’/CD
treatment/NN
./.
====================
For/IN
instance/NN
,/,
doctors/VBZ
and/CC
researchers/NNS
may/MD
be/VB
interested/VBN
in/IN
finding/NN
health/NN
records/VBZ
of/IN
patients/NNS
treated/VBN
with/IN
a/DT
particular/JJ
kind/NN
of/IN
compound/NN
in/IN
order/NN
to/TO
manually/RB
analyze/VB
them/PRP
or/CC
use/NN
them/PRP
in/IN
biomedical/JJ
NLP/NN
pipelines/NNS
./.
====================
Nevertheless/RB
,/,
the/DT
task/NN
of/IN
manually/RB
detecting/VBG
these/DT
entities/NNS
would/MD
be/VB
expensive/JJ
and/CC
time-consuming/JJ
,/,
which/WDT
prompts/VBZ
for/IN
the/DT
development/NN
of/IN
NER/NN
systems/NNS
for/IN
automating/VBG
this/DT
task/NN
./.
====================
In/IN
the/DT
context/NN
of/IN
chemical/JJ
compounds/NNS
,/,
NER/NN
is/VBZ
usually/RB
referred/VBN
to/TO
as/IN
chemical/JJ
entity/NN
recognition/NN
(/(
CER/NN
)/)
./.
====================
Challenges/NNS
in/IN
NER/NN
for/IN
medical/JJ
texts/NNS
and/CC
chemical/JJ
compounds/NNS
====================
NER/NN
itself/PRP
has/VBZ
proven/VBN
to/TO
be/VB
a/DT
challenging/JJ
task/NN
because/IN
of/IN
the/DT
ambiguity/NN
and/CC
complexity/NN
of/IN
human/JJ
languages/NNS
./.
====================
In/IN
the/DT
particular/JJ
case/NN
of/IN
CER/NN
,/,
additional/JJ
difficulties/NNS
arise/VBP
./.
====================
First/RB
of/IN
all/DT
,/,
not/RB
all/DT
chemical/JJ
names/NNS
present/JJ
distinctive/JJ
patterns/NNS
as/IN
far/RB
as/IN
name/RB
segments/NNS
or/CC
chemical/JJ
word/NN
morphology/NN
are/VBP
concerned/VBN
./.
====================
CER/NN
systems/NNS
are/VBP
particularly/RB
sensitive/JJ
with/IN
regard/NN
to/TO
both/CC
spelling/JJ
errors/NNS
and/CC
the/DT
tokenization/NN
strategy/NN
of/IN
choice/NN
since/IN
chemical/JJ
documents/NNS
usually/RB
exhibit/VBP
hyphenated/JJ
text/RB
segments/NNS
or/CC
variable/JJ
use/NN
of/IN
parentheses/NNS
,/,
brackets/NNS
,/,
dots/NNS
,/,
and/CC
other/JJ
punctuation/NN
signs/NNS
./.
====================
In/IN
addition/NN
,/,
chemical/JJ
documents/NNS
tend/NN
to/TO
be/VB
loaded/VBN
with/IN
acronyms/NNS
and/CC
abbreviations/NNS
,/,
which/WDT
are/VBP
one/CD
of/IN
the/DT
main/JJ
sources/NNS
of/IN
false/JJ
positives/VBZ
./.
====================
Another/DT
characteristic/JJ
that/DT
makes/VBZ
CER/NN
difficult/JJ
is/VBZ
the/DT
fact/NN
that/IN
the/DT
detection/NN
of/IN
mention/NN
boundaries/NNS
is/VBZ
especially/RB
cumbersome/NN
when/WRB
long/JJ
chemicals/NNS
or/CC
modifiers/NNS
are/VBP
present/JJ
./.
====================
A/DT
more/RBR
in-depth/IN
description/NN
of/IN
difficulties/NNS
in/IN
tagging/VBG
chemicals/NNS
can/MD
be/VB
found/VBN
at/IN
[/(
6/CD
]/)
./.
====================
Other/JJ
approaches/NNS
====================
In/IN
the/DT
past/NN
,/,
most/JJS
NER/NN
systems/NNS
were/VBD
rule-based/VBN
or/CC
leveraged/JJ
graph-based/VBN
models/NNS
such/JJ
as/IN
CRFs/NNS
,/,
while/IN
nowadays/RB
the/DT
task/NN
is/VBZ
usually/RB
approached/VBN
with/IN
deep/JJ
learning/VBG
techniques/NNS
./.
====================
In/IN
the/DT
case/NN
of/IN
CER/NN
systems/NNS
,/,
we/PRP
can/MD
highlight/VB
some/DT
relevant/JJ
works/NNS
./.
====================
ChemicalTagger/RBR
[/(
7/CD
]/)
parsed/VBN
the/DT
text/NN
with/IN
a/DT
formal/JJ
grammar/JJ
and/CC
domain-specific/JJ
regular/JJ
expressions/NNS
(/(
regex/NN
)/)
and/CC
used/VBN
the/DT
parse/JJ
tree/CD
in/IN
combination/NN
with/IN
the/DT
Part-of-Speech/NN
(/(
POS/NNS
)/)
tags/NNS
obtained/VBN
with/IN
an/DT
English/NN
tagger/NN
in/IN
order/NN
to/TO
extract/NN
chemical/JJ
entities/VBZ
./.
====================
They/PRP
reported/VBD
achieving/VBG
machine-annotator/NN
agreements/NNS
of/IN
88.9/CD
%/NN
for/IN
phrase/NN
recognition/NN
and/CC
91.9/CD
%/NN
for/IN
phrase-type/JJ
identification/NN
./.
====================
The/DT
test/NN
corpus/NN
was/VBD
assembled/VBN
by/IN
compiling/VBG
50/CD
paragraphs/NNS
from/IN
the/DT
experimental/JJ
sections/NNS
of/IN
polymer/NN
synthesis/NN
related/JJ
papers/NNS
./.
====================
CheNER/NN
[/(
8/CD
]/)
,/,
a/DT
tool/NN
for/IN
the/DT
identification/NN
of/IN
chemical/JJ
entities/VBZ
and/CC
their/PRP$
classes/NNS
in/IN
the/DT
biomedical/JJ
literature/NN
,/,
is/VBZ
based/VBN
on/IN
a/DT
combination/NN
of/IN
CRFs/NNS
,/,
regex/JJ
and/CC
dictionary/JJ
matching/VBG
./.
====================
An/DT
F-Score/NN
of/IN
about/RB
73/CD
%/NN
was/VBD
reported/VBN
,/,
with/IN
minor/JJ
differences/NNS
depending/VBG
on/IN
the/DT
particular/JJ
experiment/NN
./.
====================
For/IN
evaluation/NN
,/,
two/CD
corpora/NN
containing/VBG
3,500/CD
documents/VBZ
with/IN
approximately/RB
29,500/CD
annotated/JJ
chemical/JJ
entities/VBZ
divided/VBN
into/IN
several/JJ
classes/NNS
were/VBD
used/VBN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
MetaMap/NNP
[/(
8/CD
]/)
,/,
a/DT
tool/NN
for/IN
recognizing/VBG
Unified/JJ
Medical/JJ
Language/JJ
System/NN
(/(
UMLS/NNS
)/)
concepts/VBZ
in/IN
the/DT
text/NN
,/,
mapped/VBD
entities/VBZ
to/TO
UMLS/NN
concepts/NNS
by/IN
the/DT
means/NNS
of/IN
rules/NNS
and/CC
a/DT
parser/NN
./.
====================
In/IN
CHEMDNER/NN
[/(
6/CD
]/)
,/,
a/DT
drug/NN
and/CC
chemical/JJ
names/NNS
extraction/NN
competition/NN
,/,
the/DT
top/NN
scoring/VBG
teams/NNS
obtained/VBN
F-scores/NNS
of/IN
87.39/CD
%/NN
and/CC
88.2/CD
%/NN
depending/VBG
on/IN
the/DT
particular/JJ
task/NN
,/,
employing/VBG
CRFs/NNS
and/CC
domain-specific/JJ
rules/NNS
./.
====================
These/DT
scores/NNS
were/VBD
obtained/VBN
in/IN
the/DT
CHEMDNER/NN
corpus/NN
,/,
a/DT
dataset/NN
with/IN
chemical/JJ
compounds/NNS
manually/RB
annotated/JJ
by/IN
domain/NN
experts/VBZ
./.
====================
With/IN
regard/NN
to/TO
drug/NN
recognition/NN
,/,
a/DT
vast/JJ
survey/NN
on/IN
approaches/NNS
and/CC
resources/VBZ
was/VBD
presented/VBN
in/IN
Liu/JJ
et/FW
al./FW
’/CD
s/NNS
study/NN
[/(
9/CD
]/)
,/,
including/VBG
classical/JJ
machine/NN
learning/VBG
techniques/NNS
and/CC
hybrid/NN
approaches/NNS
./.
====================
The/DT
authors/NNS
suggested/VBD
using/VBG
deep/JJ
learning/VBG
techniques/NNS
for/IN
drug/NN
recognition/NN
as/IN
future/JJ
work/NN
./.
====================
A/DT
system/NN
for/IN
drug/NN
name/NN
recognition/NN
and/CC
classification/NN
in/IN
biomedical/JJ
texts/NNS
was/VBD
introduced/VBN
in/IN
Segura-Bedmar/JJ
et/FW
al./FW
’/CD
s/NNS
study/NN
[/(
10/CD
]/)
./.
====================
By/IN
combining/VBG
information/NN
obtained/VBN
by/IN
the/DT
UMLS/NN
MetaMap/NN
Transfer/NN
(/(
MMTx/NN
)/)
program/NN
and/CC
nomenclature/NN
rules/NNS
recommended/VBN
by/IN
the/DT
World/NN
Health/NN
Organization/NN
(/(
WHO/NN
)/)
INNs/NNS
Program/NN
,/,
a/DT
broader/JJR
coverage/NN
than/IN
previous/JJ
approaches/NNS
based/VBN
on/IN
standalone/NN
MMTx/NN
was/VBD
achieved/VBN
./.
====================
For/IN
an/DT
extensive/JJ
review/NN
of/IN
text/JJ
mining/JJ
techniques/NNS
for/IN
drugs/NNS
and/CC
chemical/JJ
compounds/NNS
,/,
readers/VBZ
can/MD
refer/VB
to/TO
Vazquez/NN
et/FW
al./FW
’/CD
s/NNS
study/NN
[/(
11/CD
]/)
./.
====================
Nevertheless/RB
,/,
the/DT
aforementioned/VBN
works/NNS
used/VBN
techniques/NNS
that/DT
have/VBP
some/DT
important/JJ
limitations/NNS
[/(
1/CD
]/)
./.
====================
Dictionary-based/VBN
methods/NNS
have/VBP
problems/NNS
dealing/VBG
with/IN
name/NN
variability/NN
since/IN
chemical/JJ
naming/VBG
exhibits/VBZ
high/JJ
variation/NN
./.
====================
Rule/NN
construction/NN
,/,
apart/VBP
from/IN
requiring/VBG
domain/NN
knowledge/NN
and/CC
an/DT
extensive/JJ
manual/JJ
workload/NN
,/,
has/VBZ
proven/VBN
to/TO
be/VB
difficult/JJ
to/TO
scale/VB
to/TO
new/JJ
rules/NNS
and/CC
to/TO
transfer/VB
to/TO
slightly/RB
different/JJ
domains/NNS
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
statistical/JJ
models/NNS
such/JJ
as/IN
CRFs/NNS
and/CC
classic/JJ
machine/NN
learning/VBG
algorithms/NNS
are/VBP
not/RB
powerful/JJ
enough/IN
for/IN
detecting/VBG
some/DT
patterns/NNS
and/CC
require/VB
a/DT
certain/JJ
amount/NN
of/IN
feature/NN
engineering/VBG
./.
====================
All/DT
these/DT
previous/JJ
approaches/NNS
focused/VBN
on/IN
data/NNS
in/IN
English/NN
,/,
despite/IN
the/DT
fact/NN
that/IN
there/EX
is/VBZ
a/DT
considerable/JJ
amount/NN
of/IN
textual/JJ
data/NNS
and/CC
repositories/VBZ
(/(
e.g./FW
,/,
MEDES/NNS
,/,
Scielo/NNP
,/,
Ibecs/NNP
,/,
or/CC
Cuiden/JJ
)/)
,/,
as/IN
well/RB
as/IN
a/DT
large/JJ
medical/JJ
end/NN
users/NNS
community/NN
interested/JJ
in/IN
tools/NNS
for/IN
processing/NN
data/NNS
in/IN
Spanish/JJ
./.
====================
Regarding/VBG
other/JJ
languages/NNS
,/,
this/DT
work/NN
[/(
12/CD
]/)
presented/VBN
a/DT
system/NN
based/VBN
on/IN
CRFs/NNS
that/DT
was/VBD
capable/JJ
of/IN
recognizing/VBG
entities/VBZ
in/IN
French/JJ
biomedical/JJ
documents/VBZ
./.
====================
Our/PRP$
proposal/NN
====================
Our/PRP$
proposal/JJ
involves/VBZ
the/DT
adaption/NN
of/IN
a/DT
state-of-the-art/NN
NER/NN
(/(
i.e./FW
,/,
NeuroNER/NN
)/)
based/VBN
on/IN
deep/NN
learning/VBG
to/TO
the/DT
particular/JJ
domain/NN
of/IN
the/DT
Spanish/JJ
medical/JJ
texts/NNS
in/IN
order/NN
to/TO
identify/VB
identities/VBZ
as/IN
proteins/NNS
or/CC
other/JJ
components/NNS
./.
====================
Remarkably/RB
,/,
the/DT
system/NN
we/PRP
base/NN
our/PRP$
work/NN
on/IN
has/VBZ
a/DT
CRF/NN
layer/NN
apart/NN
from/IN
deep/JJ
learning/VBG
components/NNS
./.
====================
The/DT
original/JJ
system/NN
takes/VBZ
tokens/NNS
as/IN
its/PRP$
input/NN
,/,
while/IN
our/PRP$
proposal/NN
involves/VBZ
using/VBG
additional/JJ
features/NNS
in/IN
the/DT
neural/JJ
network/NN
./.
====================
Key/NN
innovations/NNS
====================
Our/PRP$
contribution/NN
consists/VBZ
in/IN
extending/VBG
an/DT
existing/VBG
neural/JJ
NER/NN
system/NN
with/IN
additional/JJ
features/NNS
that/DT
had/VBD
worked/VBN
with/IN
classic/JJ
CERs/NNS
./.
====================
In/IN
particular/JJ
,/,
POS/NN
tags/NNS
,/,
gazetteer/NN
features/NNS
,/,
and/CC
affixes/NNS
features/NNS
have/VBP
been/VBN
added/VBN
to/TO
the/DT
network/NN
and/CC
were/VBD
as/IN
a/DT
pre-preprocessing/JJ
step/NN
./.
====================
Different/JJ
experiments/NNS
have/VBP
been/VBN
conducted/VBN
in/IN
order/NN
to/TO
determine/VB
whether/IN
these/DT
features/NNS
improved/JJ
the/DT
performance/NN
of/IN
the/DT
neural/JJ
network/NN
./.
====================
The/DT
extension/NN
of/IN
the/DT
neural/JJ
network/NN
is/VBZ
domain/NN
and/CC
language-agnostic/JJ
,/,
while/IN
the/DT
pre-processing/VBG
is/VBZ
domain-dependent/JJ
and/CC
specific/JJ
tools/NNS
for/IN
Spanish/JJ
medical/JJ
texts/NNS
have/VBP
been/VBN
used/VBN
./.
====================
By/IN
the/DT
neural/JJ
network/NN
itself/PRP
being/VBG
language-agnostic/JJ
we/PRP
mean/VBP
that/DT
our/PRP$
system/NN
could/MD
be/VB
adapted/VBN
to/TO
other/JJ
languages/NNS
by/IN
building/VBG
gazetteer/NN
and/CC
affix/IN
dictionaries/NNS
and/CC
using/VBG
a/DT
POS/NN
tagger/NN
trained/VBN
for/IN
the/DT
required/VBN
language/JJ
./.
====================
NeuroNER/NN
,/,
an/DT
open-source/NN
program/NN
for/IN
named-entity/NN
recognition/NN
,/,
achieved/VBD
state-of-the-art/RB
performance/RB
by/IN
having/VBG
a/DT
neural/JJ
architecture/NN
containing/VBG
three/CD
layers/NNS
:/:
(/(
1/CD
)/)
character-enhanced/VBD
token-embedding/VBG
layer/NN
,/,
(/(
2/CD
)/)
a/DT
label/JJ
prediction/NN
layer/NN
,/,
and/CC
(/(
3/CD
)/)
a/DT
label/JJ
sequence/NN
optimization/NN
layer/NN
./.
====================
Recurrent/JJ
neural/JJ
networks/NNS
(/(
RNNs/NNS
)/)
are/VBP
ANNs/NNS
such/JJ
that/IN
the/DT
computational/JJ
graphs/NNS
have/VBP
cycles/NNS
,/,
which/WDT
are/VBP
used/VBN
for/IN
dealing/VBG
with/IN
sequences/NNS
[/(
13/CD
]/)
./.
====================
Long/JJ
short/JJ
term/NN
memory/NN
(/(
LSTM/NN
)/)
[/(
14/CD
]/)
are/VBP
gated/VBN
units/NNS
widely/RB
used/VBN
in/IN
RNN/NN
implementations/NNS
./.
====================
A/DT
Bidirectional/JJ
LSTM/NN
(/(
Bi-LSTM/NN
)/)
is/VBZ
an/DT
LSTM/NN
unit/NN
such/JJ
that/IN
two/CD
inputs/NNS
layers/NNS
with/IN
opposite/JJ
directions/NNS
are/VBP
present/JJ
,/,
which/WDT
allows/VBZ
the/DT
network/NN
to/TO
get/VB
information/NN
from/IN
both/DT
the/DT
past/NN
and/CC
future/JJ
states/NNS
simultaneously/RB
./.
====================
NeuroNER/NN
makes/VBZ
use/NN
of/IN
Bi-LSTM/NN
for/IN
the/DT
character-enhanced/JJ
token-embedding/VBG
layer/NN
,/,
while/IN
character/NN
embeddings/NNS
are/VBP
previously/RB
passed/VBN
through/IN
their/PRP$
own/JJ
LSTM/NN
./.
====================
In/IN
Fig/NN
./.
====================
1/CD
,/,
we/PRP
show/VBP
a/DT
representation/NN
of/IN
the/DT
ANN/NN
in/IN
the/DT
original/JJ
NeuroNER/NN
implementation/NN
./.
====================
We/PRP
must/MD
notice/RB
that/DT
this/DT
is/VBZ
just/RB
a/DT
snippet/NN
of/IN
the/DT
structure/NN
of/IN
one/CD
token/NN
./.
====================
The/DT
full/JJ
ANN/NN
has/VBZ
connections/NNS
for/IN
the/DT
RNN/NN
between/IN
tokens/NNS
from/IN
the/DT
character-enhanced/JJ
token/VBN
embedding/VBG
upwards/IN
./.
====================
For/IN
details/VBZ
about/RB
this/DT
model/NN
,/,
readers/VBZ
can/MD
refer/VB
to/TO
Dernoncourt/VB
et/FW
al/JJ
./.
====================
[/(
15/CD
]/)
./.
====================
In/IN
addition/NN
,/,
NeuroNER/NN
has/VBZ
the/DT
ability/NN
to/TO
load/JJ
pre-trained/VBD
token/VBN
embeddings/NNS
,/,
which/WDT
may/MD
increase/VB
final/JJ
performance/NN
and/CC
decrease/NN
training/VBG
time/NN
./.
====================
For/IN
more/RBR
details/NNS
about/RB
NeuroNER/NN
,/,
please/NN
refer/VBP
to/TO
the/DT
following/VBG
related/JJ
works/NNS
:/:
Dernoncourt/JJ
et/FW
al/JJ
./.
====================
[/(
5,15/CD
]/)
./.
====================
The/DT
following/VBG
features/NNS
have/VBP
been/VBN
added/VBN
to/TO
both/CC
the/DT
neural/JJ
network/NN
and/CC
the/DT
dataset/NN
parser/NN
of/IN
NeuroNER/NN
:/:
====================
‒/RB
POS/NN
features/NNS
:/:
with/IN
our/PRP$
modification/NN
,/,
PharmacoNER/NN
tagger/RBR
can/MD
parse/VB
annotations/NNS
(/(
both/CC
in/FW
BRAT/NN
or/CC
CONLL/NN
formats/NNS
)/)
of/IN
POS/NN
tags/NNS
,/,
encode/VBP
them/PRP
with/IN
a/DT
one-hot/JJ
encoding/VBG
for/IN
each/DT
token/VBN
and/CC
include/VBP
this/DT
in/IN
the/DT
token/NN
embedding/VBG
layer/NN
of/IN
the/DT
network/NN
./.
====================
‒/DT
Gazetteer/NN
features/NNS
:/:
our/PRP$
modified/VBN
version/NN
of/IN
NeuroNER/NN
is/VBZ
able/JJ
to/TO
parse/JJ
a/DT
text/JJ
file/JJ
with/IN
terms/NNS
related/JJ
to/TO
the/DT
target/NN
entities/VBZ
,/,
build/JJ
a/DT
dictionary/JJ
and/CC
assign/NN
a/DT
positive/JJ
value/NN
for/IN
the/DT
words/NNS
that/DT
are/VBP
found/VBN
in/IN
this/DT
dictionary/JJ
./.
====================
This/DT
feature/NN
is/VBZ
then/RB
concatenated/VBD
with/IN
the/DT
character-enhanced/JJ
token/NN
embedding/VBG
layer/NN
./.
====================
A/DT
file/JJ
with/IN
the/DT
dictionary/JJ
has/VBZ
to/TO
be/VB
supplied/VBN
by/IN
the/DT
user/NN
./.
====================
‒/DT
Affixes/NNS
features/NNS
:/:
PharmacoNER/NN
tagger/NN
can/MD
use/VB
information/NN
regarding/VBG
affixes/NNS
in/IN
a/DT
similar/JJ
manner/NN
as/IN
the/DT
gazetteer/NN
features/NNS
,/,
but/CC
using/VBG
regular/JJ
expressions/NNS
to/TO
detect/VB
whether/IN
a/DT
particular/JJ
word/NN
has/VBZ
an/DT
affix/NN
related/JJ
to/TO
the/DT
target/NN
entities/VBZ
./.
====================
A/DT
file/JJ
of/IN
affixes/NNS
shall/DT
be/VB
supplied/VBN
by/IN
the/DT
user/NN
./.
====================
Notice/RB
that/DT
the/DT
aforementioned/VBN
features/NNS
are/VBP
domain/NN
and/CC
language/NN
independent/JJ
./.
====================
The/DT
final/JJ
software/JJ
can/MD
be/VB
found/VBN
in/IN
Github/NN
(/(
https/NNS
:/:
//github.com/PlanTL-SANIDAD/PharmacoNER/NN
)/)
,/,
with/IN
information/NN
about/IN
installation/NN
and/CC
samples/NNS
./.
====================
In/IN
Fig/NN
./.
====================
2/CD
,/,
the/DT
adaptation/NN
of/IN
the/DT
neural/JJ
network/NN
is/VBZ
also/RB
depicted/VBD
,/,
showing/VBG
the/DT
differences/NNS
from/IN
Fig/NN
./.
====================
1/CD
./.
====================
Data/NNS
====================
For/IN
evaluating/VBG
PharmacoNER/NN
tagger/NN
,/,
we/PRP
used/VBD
the/DT
SPACCC/NN
dataset/NN
,/,
a/DT
manually/RB
annotated/JJ
corpus/NN
of/IN
1,000/CD
clinical/JJ
cases/NNS
written/CD
in/IN
Spanish/JJ
and/CC
annotated/JJ
with/IN
mentions/NNS
of/IN
chemical/JJ
compounds/NNS
,/,
drugs/NNS
,/,
genes/NNS
,/,
and/CC
proteins/NNS
./.
====================
In/IN
particular/JJ
,/,
the/DT
set/NN
of/IN
labels/NNS
consists/VBZ
of/IN
Normalizables/NNS
(/(
4,398/CD
labels/NNS
)/)
,/,
No/DT
Normalizables/NNS
(/(
50/CD
labels/NNS
)/)
,/,
Proteins/NNS
(/(
3,009/CD
labels/NNS
)/)
,/,
and/CC
Unclear/JJ
(/(
167/CD
labels/NNS
)/)
./.
====================
Note/RB
that/DT
Normalizables/NNS
and/CC
No/DT
Normalizables/NNS
refer/VBP
to/TO
chemical/JJ
entities/VBZ
./.
====================
For/IN
instance/NN
,/,
the/DT
word/NN
“/CD
triglicéridos/NN
”/CD
(/(
triglycerides/NNS
)/)
is/VBZ
annotated/VBN
as/IN
Normalizable/JJ
,/,
while/IN
“/CD
receptores/NNS
de/FW
progesterona/NN
”/CD
(/(
progesterone/NN
receptors/NNS
)/)
is/VBZ
labelled/VBN
as/IN
Proteins/NNS
./.
====================
One/CD
can/MD
notice/RB
that/DT
the/DT
dataset/NN
is/VBZ
heavily/RB
imbalanced/JJ
./.
====================
The/DT
dataset/NN
has/VBZ
not/RB
been/VBN
released/VBN
yet/RB
due/JJ
to/TO
an/DT
ongoing/JJ
shared/JJ
task/NN
(/(
http/NN
:/:
//temu.bsc.es/pharmaconer/NN
)/)
./.
====================
Embeddings/NNS
====================
Eight/CD
different/JJ
pre-trained/VBN
word/NN
embeddings/NNS
have/VBP
been/VBN
tested/VBN
,/,
from/IN
the/DT
Spanish/JJ
Billion/NN
Word/NN
Corpus/NN
(/(
SBWC/NN
)/)
and/CC
data/NNS
crawled/VBD
from/IN
SciELO/NNP
(/(
http/NN
:/:
//www.scielo.org/JJ
)/)
and/CC
health-related/JJ
categories/NNS
of/IN
Wikipedia/NN
./.
====================
SBWC/NN
data/NNS
is/VBZ
general-domain/JJ
,/,
while/IN
SciELO/NN
and/CC
Wikipedia/NN
are/VBP
in-domain/RB
./.
====================
‒/CD
General/JJ
domain/NN
(/(
Universidad/JJ
de/FW
Chile/JJ
Spanish/JJ
Word/NN
Embeddings/NNS
,/,
https/VBZ
:/:
//github.com/uchile-nlp/spanish-word-embeddings/NNS
)/)
:/:
====================
FastText/NN
embeddings/NNS
from/IN
SBWC/NN
====================
GloVe/NN
embeddings/NNS
from/IN
SBWC/NN
====================
-/:
Domain-specific/JJ
(/(
PlanTL/NN
Embeddings/NNS
,/,
https/VBZ
:/:
//github.com/PlanTL-SANIDAD/Embeddings/NNS
)/)
:/:
====================
FastText/NN
Scielo/JJ
====================
FastText/NN
medical/JJ
Wikipedia/NN
====================
FastText/NN
Scielo/JJ
+/JJ
Health/NN
Wikipedia/NN
====================
Word2Vec/NNP
Scielo/JJ
====================
Word2Vec/NNP
medical/JJ
Wikipedia/NN
====================
Word2Vec/NNP
Scielo/JJ
+/JJ
Health/NN
Wikipedia/NN
====================
Sampling/VBG
====================
The/DT
SPACCC/NN
dataset/NN
was/VBD
split/NN
with/IN
the/DT
following/VBG
proportions/NNS
:/:
80/CD
%/NN
for/IN
training/VBG
,/,
10/CD
%/NN
for/IN
validation/NN
,/,
and/CC
10/CD
%/NN
for/IN
test/NN
./.
====================
Since/IN
the/DT
dataset/NN
is/VBZ
imbalanced/JJ
,/,
a/DT
stratified/JJ
splitting/NN
has/VBZ
been/VBN
applied/VBN
,/,
in/IN
order/NN
to/TO
approximately/RB
maintain/VBP
the/DT
same/JJ
proportions/NNS
of/IN
labels/NNS
in/IN
the/DT
three/CD
sets/NNS
./.
====================
SPACCC/NN
POS/NN
tagger/NN
and/CC
freeling/JJ
====================
FreeLing/VBG
[/(
16/CD
]/)
is/VBZ
an/DT
open/JJ
source/NN
language/NN
analysis/NN
tool/NN
suite/JJ
,/,
released/VBD
under/IN
the/DT
Affero/JJ
GNU/NN
General/JJ
Public/JJ
License/JJ
of/IN
the/DT
Free/JJ
Software/JJ
Foundation/NN
./.
====================
FreeLing/VBG
was/VBD
used/VBN
for/IN
building/VBG
the/DT
SPACCC/NN
POS/NN
Tagger/NN
(/(
https/NNS
:/:
//github.com/PlanTL-SANIDAD/NN
)/)
,/,
which/WDT
is/VBZ
a/DT
POS/NN
tagger/NN
trained/VBN
with/IN
Spanish/JJ
medical/JJ
texts/NNS
./.
====================
SPACCC/NN
POS/NN
Tagger/NN
was/VBD
successfully/RB
applied/VBN
to/TO
the/DT
provided/VBN
data/NNS
as/IN
a/DT
pre-processing/JJ
step/NN
./.
====================
Gazetteer/NN
====================
The/DT
gazetteer/NN
dictionary/JJ
was/VBD
built/JJ
with/IN
a/DT
pharmaceutical/JJ
“/CD
nomenclator/NN
”/CD
maintained/VBD
by/IN
the/DT
Spanish/JJ
government/JJ
(/(
https/NNS
:/:
//www.mscbs.gob.es/profesionales/nomenclator.do/JJ
)/)
,/,
which/WDT
consists/VBZ
of/IN
drug/NN
names/NNS
and/CC
active/JJ
components/NNS
of/IN
medicines/NNS
./.
====================
For/IN
instance/NN
,/,
indomethacin/NN
is/VBZ
listed/VBN
as/IN
an/DT
active/JJ
ingredient/JJ
,/,
and/CC
therefore/RB
the/DT
appearances/NNS
of/IN
this/DT
particular/JJ
word/NN
are/VBP
marked/JJ
as/IN
belonging/VBG
to/TO
the/DT
dictionary/JJ
./.
====================
List/NN
of/IN
affixes/NNS
====================
The/DT
list/NN
of/IN
affixes/NNS
was/VBD
retrieved/VBN
from/IN
a/DT
biomedical/JJ
website/JJ
(/(
http/NN
:/:
//blog.nclexmastery.com/drug-stems-prefixes-roots-suffixes//JJ
)/)
and/CC
translated/VBN
into/IN
Spanish/JJ
./.
====================
The/DT
final/JJ
format/IN
is/VBZ
a/DT
tab-separated/JJ
file/JJ
,/,
with/IN
the/DT
type/NN
of/IN
affix/JJ
(/(
e.g./FW
,/,
suffix/JJ
,/,
prefix/JJ
,/,
or/CC
root/NN
)/)
,/,
the/DT
affix/JJ
in/IN
English/NN
,/,
the/DT
affix/JJ
in/IN
Spanish/JJ
,/,
an/DT
example/NN
in/IN
English/NN
and/CC
the/DT
Drug/NN
class/NN
./.
====================
For/IN
PharmacoNER/NN
tagger/NN
,/,
only/RB
the/DT
columns/NNS
type/NN
,/,
and/CC
affix/NN
in/IN
Spanish/JJ
are/VBP
used/VBN
./.
====================
Metrics/NNS
====================
The/DT
CONLL/NN
evaluation/NN
script/NN
is/VBZ
used/VBN
for/IN
evaluating/VBG
the/DT
results/NNS
./.
====================
The/DT
following/VBG
overall/JJ
metrics/NNS
are/VBP
computed/VBN
:/:
accuracy/NN
,/,
precision/NN
,/,
recall/NN
,/,
F1/NN
score/RB
./.
====================
For/IN
details/VBZ
about/RB
the/DT
metrics/NNS
,/,
please/NN
refer/VBP
to/TO
Krallinger/NN
et/FW
al./FW
’/CD
s/NNS
study/NN
[/(
1/CD
]/)
./.
====================
For/IN
the/DT
sake/NN
of/IN
comparison/NN
,/,
we/PRP
will/MD
utilize/VB
the/DT
F1/NN
score/RB
as/IN
the/DT
primary/JJ
performance/NN
metric/JJ
./.
====================
Results/NNS
with/IN
the/DT
best/JJS
configuration/NN
====================
To/TO
train/VB
our/PRP$
system/NN
,/,
we/PRP
tested/VBD
several/JJ
configurations/NNS
with/IN
various/JJ
levels/NNS
,/,
which/WDT
are/VBP
now/RB
described/VBN
:/:
====================
‒/CD
Pre-trained/JJ
embeddings/NNS
:/:
Total/JJ
of/IN
eight/CD
models/NNS
,/,
from/IN
general/JJ
domain/NN
and/CC
in-domain/FW
./.
====================
‒/CD
POS/NN
:/:
Yes/NNS
(/(
using/VBG
POS/NN
)/)
and/CC
No/DT
(/(
without/IN
POS/NN
information/NN
)/)
====================
‒/CD
Gazetteer/NN
:/:
Yes/NNS
(/(
with/IN
gazetteer/NN
)/)
and/CC
No/DT
(/(
without/IN
gazetteer/NN
)/)
====================
‒/CD
Affixes/NNS
:/:
Yes/NNS
(/(
with/IN
affix/NN
information/NN
)/)
and/CC
No/DT
(/(
without/IN
affix/CD
information/NN
)/)
./.
====================
We/PRP
trained/VBD
our/PRP$
systems/NNS
until/IN
convergence/NN
,/,
that/DT
is/VBZ
until/IN
no/DT
improvement/JJ
was/VBD
identified/VBN
in/IN
the/DT
development/NN
set/NN
for/IN
at/IN
least/JJS
10/CD
epochs/NNS
./.
====================
In/IN
addition/NN
,/,
given/VBN
that/DT
the/DT
number/NN
of/IN
samples/NNS
from/IN
the/DT
classes/NNS
No/DT
Normalizables/NNS
and/CC
Unclear/JJ
are/VBP
too/RB
small/JJ
,/,
we/PRP
decided/VBD
to/TO
discard/JJ
those/DT
classes/NNS
./.
====================
This/DT
led/VBD
our/PRP$
NER/NN
system/NN
to/TO
have/VB
the/DT
goal/NN
of/IN
identifying/VBG
Proteins/NNS
and/CC
Normalizable/JJ
chemicals/NNS
./.
====================
First/RB
of/IN
all/DT
,/,
to/TO
narrow/JJ
down/RB
the/DT
search/NN
space/NN
,/,
we/PRP
turned/VBD
off/IN
all/DT
additional/JJ
features/NNS
and/CC
just/RB
tested/VBN
the/DT
word/NN
embeddings/NNS
./.
====================
Once/RB
the/DT
best/JJS
embedding/VBG
was/VBD
found/VBN
,/,
we/PRP
fixed/VBD
it/PRP
and/CC
tested/VBN
the/DT
other/JJ
configurations/NNS
./.
====================
In/IN
Table/JJ
1/CD
,/,
we/PRP
present/VBP
the/DT
result/NN
of/IN
our/PRP$
system/NN
regarding/VBG
the/DT
metrics/NNS
mentioned/JJ
in/IN
Section/NN
4.7/CD
./.
====================
The/DT
final/JJ
setting/VBG
is/VBZ
:/:
POS/NN
with/IN
Gazetteer/NN
turned/JJ
one/CD
./.
====================
One/CD
can/MD
notice/RB
that/DT
there/EX
is/VBZ
not/RB
a/DT
great/JJ
difference/NN
between/IN
the/DT
validation/NN
and/CC
the/DT
test/NN
set/NN
in/IN
all/DT
metrics/NNS
,/,
thus/RB
meaning/VBG
that/DT
no/DT
overfitting/JJ
occurred/VBD
./.
====================
In/IN
this/DT
article/NN
we/PRP
have/VBP
introduced/VBN
PharmacoNER/NN
tagger/NN
,/,
a/DT
neural/JJ
NER/NN
based/VBN
on/IN
an/DT
existing/VBG
state-of-the-art/NN
system/NN
,/,
NeuroNER/NN
./.
====================
We/PRP
extended/VBD
and/CC
especially/RB
adapted/VBN
to/TO
the/DT
particular/JJ
domain/NN
of/IN
chemical/JJ
compounds/NNS
in/IN
Spanish/JJ
medical/JJ
texts/NNS
./.
====================
The/DT
results/NNS
in/IN
the/DT
validation/NN
set/NN
of/IN
the/DT
experiments/NNS
with/IN
the/DT
SPACCC/NN
dataset/NN
have/VBP
showed/VBD
that/IN
the/DT
best/JJS
configuration/NN
consisted/VBD
of/IN
the/DT
FastText/JJ
Scielo/NNP
+/CC
Health/NN
Wikipedia/NN
embeddings/NNS
,/,
the/DT
POS/NN
,/,
and/CC
the/DT
gazetteer/NN
,/,
which/WDT
have/VBP
proven/VBN
to/TO
be/VB
an/DT
additional/JJ
source/NN
of/IN
information/NN
that/IN
can/MD
be/VB
leveraged/VBN
by/IN
neural/JJ
networks/NNS
./.
====================
In/IN
the/DT
test/NN
set/NN
,/,
the/DT
aforementioned/VBN
best/JJS
configuration/NN
obtained/VBN
an/DT
F1/NN
score/RB
of/IN
89.06/CD
./.
====================
The/DT
extension/NN
to/TO
the/DT
network/NN
is/VBZ
domain-agnostic/JJ
and/CC
could/MD
be/VB
used/VBN
in/IN
other/JJ
fields/NNS
,/,
but/CC
the/DT
pre-processing/VBG
steps/NNS
have/VBP
been/VBN
specifically/RB
designed/VBN
for/IN
our/PRP$
domain/NN
./.
====================
CER/NN
involves/VBZ
additional/JJ
challenges/NNS
to/TO
the/DT
ones/NNS
already/RB
present/JJ
in/IN
generic/JJ
NER/NN
./.
====================
Our/PRP$
work/NN
shows/VBZ
that/IN
some/DT
of/IN
the/DT
sources/NNS
of/IN
additional/JJ
information/NN
typically/RB
used/VBN
in/IN
previous/JJ
CER/NN
systems/NNS
based/VBN
on/IN
non-neural/JJ
techniques/NNS
,/,
such/JJ
as/IN
affixes/NNS
,/,
can/MD
be/VB
leveraged/VBN
as/IN
well/RB
by/IN
state-of-the-art/NN
neural/JJ
NER/NN
systems/NNS
./.
====================
We/PRP
foresee/VBP
that/DT
this/DT
resource/NN
will/MD
be/VB
a/DT
valuable/JJ
contribution/NN
not/RB
only/RB
to/TO
semantically/RB
enhance/VBP
medical/JJ
texts/NNS
in/IN
Spanish/JJ
for/IN
pharmacological/JJ
and/CC
drug-related/JJ
information/NN
,/,
but/CC
it/PRP
also/RB
highlights/VBZ
a/DT
useful/JJ
approach/NN
on/IN
how/WRB
to/TO
implement/JJ
medical/JJ
NER/NN
taggers/NNS
for/IN
languages/NNS
other/JJ
than/IN
English/NN
./.
====================
Moreover/RB
,/,
PharmacoNER/NN
tagger/NN
will/MD
be/VB
a/DT
useful/JJ
competitive/JJ
baseline/NN
system/NN
and/CC
design/NN
principle/JJ
for/IN
the/DT
upcoming/VBG
PharmacoNER/NN
BioNLP/NN
2019/CD
shared/VBN
task/NN
./.
====================
Schematic/JJ
representation/NN
of/IN
the/DT
artificial/JJ
neural/JJ
networks/NNS
for/IN
a/DT
single/JJ
token/NN
in/IN
NeuroNER/NN
:/:
Snippet/JJ
of/IN
the/DT
architecture/NN
used/VBN
in/IN
NeuroNER/NN
./.
====================
The/DT
type/NN
of/IN
recurrent/JJ
neural/JJ
network/NN
(/(
RNN/NN
)/)
is/VBZ
long/JJ
short/JJ
term/NN
memory/NN
(/(
LSTM/NN
)/)
./.
====================
n/NN
is/VBZ
the/DT
number/NN
of/IN
tokens/NNS
Xi/NN
is/VBZ
the/DT
ith/NN
token/NN
./.
====================
Vr/RB
is/VBZ
the/DT
mapping/NN
from/IN
tokens/NNS
to/TO
token/VB
embeddings/NNS
./.
====================
l/RB
(/(
i/LS
)/)
is/VBZ
the/DT
number/NN
of/IN
characters/NNS
,/,
and/CC
Xi/NN
,/,
j/RB
is/VBZ
the/DT
jth/NN
character/NN
of/IN
the/DT
ith/IN
token/VBN
./.
====================
Vc/JJ
is/VBZ
the/DT
mapping/NN
from/IN
characters/NNS
to/TO
character/NN
embeddings/NNS
./.
====================
ei/NNS
is/VBZ
the/DT
character-enhanced/JJ
token/NN
embeddings/NNS
of/IN
the/DT
ith/NN
token/NN
./.
====================
di/RB
is/VBZ
the/DT
output/NN
of/IN
the/DT
LSTM/NN
of/IN
label/JJ
prediction/NN
layer/NN
,/,
ai/CC
is/VBZ
the/DT
probability/NN
vector/NN
over/IN
labels/NNS
,/,
and/CC
yi/FW
is/VBZ
the/DT
predicted/VBN
label/NN
of/IN
the/DT
ith/IN
token/VBN
./.
====================
Adapted/JJ
from/IN
Dernoncourt/NN
et/FW
al/JJ
./.
====================
J/NN
Am/NNP
Med/JJ
Inform/NN
Assoc/NN
2017/CD
;/:
24:596-606/CD
[/(
15/CD
]/)
./.
====================
Schematic/JJ
representation/NN
of/IN
the/DT
the/DT
artificial/JJ
neural/JJ
networks/NNS
for/IN
a/DT
single/JJ
token/NN
in/IN
PharmacoNER/NN
tagger/NN
:/:
Snippet/JJ
of/IN
the/DT
architecture/NN
used/VBN
in/IN
PharmacoNER/NN
tagger/NN
./.
====================
All/DT
notations/NNS
are/VBP
the/DT
same/JJ
as/IN
in/IN
Fig/NN
./.
====================
1/CD
./.
====================
We/PRP
added/VBD
the/DT
following/VBG
features/NNS
in/IN
the/DT
character-enhanced/JJ
token/VBN
embeddings/NNS
:/:
Vp/JJ
is/VBZ
the/DT
mapping/NN
from/IN
the/DT
specific/JJ
token/VBN
to/TO
its/PRP$
Part-of-Speech/NN
,/,
Va/NN
is/VBZ
boolean/JJ
mapping/VBG
to/TO
identify/VB
if/IN
the/DT
given/VBN
token/VBN
contains/VBZ
any/DT
of/IN
the/DT
affixes/NNS
in/IN
the/DT
database/NN
,/,
and/CC
Vg/JJ
is/VBZ
a/DT
boolean/JJ
mapping/VBG
to/TO
the/DT
gazetteer/NN
database/NN
./.
====================
RNN/NN
,/,
recurrent/JJ
neural/JJ
network/NN
./.
====================
Results/NNS
for/IN
the/DT
best/JJS
combination/NN
of/IN
embedding/VBG
and/CC
features/NNS
====================
